🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Bone marrow and peripheral stem cell transplantation may be able...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
1995-11
Trial ID
NCT00002718
The CHIP-AML22 Master protocol has the overall aim of increasing the cure r...
Status
Recruiting
Location
Princess Máxima Center for pediatric oncology
Start Date
2024-02-06
Trial ID
NCT06262438
This randomized phase III trial studies 90-yttrium ibritumomab tiuxetan and...
Status
Terminated
Location
City of Hope Medical Center
Start Date
2015-01
Trial ID
NCT02366663
RATIONALE: Drugs used in chemotherapy work in different ways to stop cancer...
Status
Completed
Location
Aurora Presbyterian Hospital
Start Date
1993-05-07
Trial ID
NCT00002514
Treatments Being Tested
The protocol is to assess the overall response rate (complete response and ...
Status
Terminated
Location
CHRU de Brest
Start Date
2013-10
Trial ID
NCT01848652
Treatments Being Tested
This study is open-label, multi-center, prospective study, which targets ch...
Status
Recruiting
Location
Kyungpook National University Chilgok Hospital
Start Date
2024-04-04
Trial ID
NCT05827549
Treatments Being Tested
This study aims to evaluate the efficacy and safety of venetoclax combined ...
Status
Recruiting
Location
Qiu Huiying
Start Date
2023-03-01
Trial ID
NCT05805098
Treatments Being Tested
This is a phase II prospective non-randomised clinical trial in newly diagn...
Status
Completed
Location
Aarhus University Hospital
Start Date
2001-10
Trial ID
NCT00791947
Treatments Being Tested
A Randomized Phase IIb Study, Evaluating Efficacy of Salvage Therapy with B...
Status
Recruiting
Location
Institut Català D'Oncologia - Hospital Germans Trias I Pujol
Start Date
2020-06-01
Trial ID
NCT04378647
It is expected that addition of anti-CD20 antibody - ofatumumab would enhan...
Status
Completed
Location
Dolnośląskie Centrum Transplantacji Komórkowych
Start Date
2011-11
Trial ID
NCT01481272